{
    "hands_on_practices": [
        {
            "introduction": "The first step in evaluating a patient with acute kidney injury (AKI) is to define and stage its severity. This practice allows you to apply the internationally recognized Kidney Disease: Improving Global Outcomes (KDIGO) criteria, a fundamental skill for any clinician. By using both serum creatinine and urine output data from a hypothetical case, you will learn to quantify the degree of renal dysfunction over time and appreciate how these two key parameters can sometimes provide different, yet complementary, information about the patient's condition. ",
            "id": "4316679",
            "problem": "An adult patient with suspected Acute Kidney Injury (AKI) is monitored using both serum creatinine and urine output over the first $72$ hours. Baseline serum creatinine is $0.8\\,\\mathrm{mg/dL}$. The patient has an indwelling urinary catheter connected to continuous drainage, and urine output within each $24$-hour block is evenly distributed across hours. No renal replacement therapy is initiated during the observation period. The patient’s body weight is $80\\,\\mathrm{kg}$. The following measurements are obtained:\n\n- Serum creatinine at $24$ hours: $1.2\\,\\mathrm{mg/dL}$; total urine output from $0$ to $24$ hours: $1600\\,\\mathrm{mL}$.\n- Serum creatinine at $48$ hours: $1.6\\,\\mathrm{mg/dL}$; total urine output from $24$ to $48$ hours: $800\\,\\mathrm{mL}$.\n- Serum creatinine at $72$ hours: $2.4\\,\\mathrm{mg/dL}$; total urine output from $48$ to $72$ hours: $500\\,\\mathrm{mL}$.\n\nUsing the standardized Kidney Disease: Improving Global Outcomes (KDIGO) criteria for AKI staging based on serum creatinine change and urine output thresholds, determine the KDIGO stage at $24$, $48$, and $72$ hours. For each time point, compute the stage independently according to the serum creatinine criteria and the urine output criteria, then determine the overall KDIGO stage using the convention that the overall stage is the more severe of the two at that time point. Briefly justify any discrepancies between creatinine-based and urine-output-based staging.\n\nReport the final KDIGO stages at $24$, $48$, and $72$ hours as three integers in a single row matrix. No rounding is required. Do not include units in the final reported answer.",
            "solution": "The objective is to determine the KDIGO stage of AKI at $24$, $48$, and $72$ hours by independently assessing serum creatinine (SCr) and urine output (UO) criteria and selecting the more severe stage for the overall classification at each time point.\n\nThe foundational data provided are:\n- Baseline serum creatinine: $SCr_{base} = 0.8\\,\\mathrm{mg/dL}$\n- Patient body weight: $BW = 80\\,\\mathrm{kg}$\n- Measurement at $t_1 = 24\\,\\mathrm{h}$: $SCr_{24} = 1.2\\,\\mathrm{mg/dL}$; Total UO over $[0, 24]\\,\\mathrm{h}$ is $V_1 = 1600\\,\\mathrm{mL}$.\n- Measurement at $t_2 = 48\\,\\mathrm{h}$: $SCr_{48} = 1.6\\,\\mathrm{mg/dL}$; Total UO over $(24, 48]\\,\\mathrm{h}$ is $V_2 = 800\\,\\mathrm{mL}$.\n- Measurement at $t_3 = 72\\,\\mathrm{h}$: $SCr_{72} = 2.4\\,\\mathrm{mg/dL}$; Total UO over $(48, 72]\\,\\mathrm{h}$ is $V_3 = 500\\,\\mathrm{mL}$.\n\nThe KDIGO staging criteria for AKI are:\n- **Stage 1**: $1.5-1.9$ times baseline SCr, OR increase in SCr by $\\ge 0.3\\,\\mathrm{mg/dL}$ (within $48\\,\\mathrm{h}$). For UO: $< 0.5\\,\\mathrm{mL/kg/h}$ for $6-12\\,\\mathrm{h}$.\n- **Stage 2**: $2.0-2.9$ times baseline SCr. For UO: $< 0.5\\,\\mathrm{mL/kg/h}$ for $\\ge 12\\,\\mathrm{h}$.\n- **Stage 3**: $\\ge 3.0$ times baseline SCr, OR SCr increase to $\\ge 4.0\\,\\mathrm{mg/dL}$, OR initiation of renal replacement therapy. For UO: $< 0.3\\,\\mathrm{mL/kg/h}$ for $\\ge 24\\,\\mathrm{h}$, OR Anuria for $\\ge 12\\,\\mathrm{h}$.\n\n**Analysis at $t = 24$ hours**\n\n1.  **Serum Creatinine (SCr) Staging**:\n    - The ratio of current SCr to baseline is $\\frac{SCr_{24}}{SCr_{base}} = \\frac{1.2\\,\\mathrm{mg/dL}}{0.8\\,\\mathrm{mg/dL}} = 1.5$. This meets the Stage $1$ criterion ($\\ge 1.5$ times baseline).\n    - The absolute increase in SCr is $SCr_{24} - SCr_{base} = 1.2\\,\\mathrm{mg/dL} - 0.8\\,\\mathrm{mg/dL} = 0.4\\,\\mathrm{mg/dL}$. This increase occurred within $24\\,\\mathrm{h}$, satisfying the Stage $1$ criterion of an increase $\\ge 0.3\\,\\mathrm{mg/dL}$ within $48\\,\\mathrm{h}$.\n    - The SCr-based stage is **Stage 1**.\n\n2.  **Urine Output (UO) Staging**:\n    - The average UO rate over the first $24\\,\\mathrm{h}$ is calculated as $\\frac{V_1}{BW \\times \\Delta t} = \\frac{1600\\,\\mathrm{mL}}{80\\,\\mathrm{kg} \\times 24\\,\\mathrm{h}} = \\frac{1600}{1920}\\,\\mathrm{mL/kg/h} \\approx 0.833\\,\\mathrm{mL/kg/h}$.\n    - This rate is not less than the threshold of $0.5\\,\\mathrm{mL/kg/h}$.\n    - The UO-based stage is **Stage 0**.\n\n3.  **Overall Staging**:\n    - The overall stage is the maximum of the two component stages: $\\max(1, 0) = 1$.\n    - The KDIGO stage at $24$ hours is **1**.\n\n**Analysis at $t = 48$ hours**\n\n1.  **Serum Creatinine (SCr) Staging**:\n    - The ratio of current SCr to baseline is $\\frac{SCr_{48}}{SCr_{base}} = \\frac{1.6\\,\\mathrm{mg/dL}}{0.8\\,\\mathrm{mg/dL}} = 2.0$. This meets the Stage $2$ criterion ($\\ge 2.0$ times baseline).\n    - The SCr-based stage is **Stage 2**.\n\n2.  **Urine Output (UO) Staging**:\n    - The average UO rate over the interval $(24, 48]\\,\\mathrm{h}$ (duration $24\\,\\mathrm{h}$) is $\\frac{V_2}{BW \\times \\Delta t} = \\frac{800\\,\\mathrm{mL}}{80\\,\\mathrm{kg} \\times 24\\,\\mathrm{h}} = \\frac{800}{1920}\\,\\mathrm{mL/kg/h} \\approx 0.417\\,\\mathrm{mL/kg/h}$.\n    - This rate is $< 0.5\\,\\mathrm{mL/kg/h}$. Since it persisted for $24\\,\\mathrm{h}$ (which is $\\ge 12\\,\\mathrm{h}$), it meets the Stage $2$ criterion. It does not meet the Stage $3$ criterion as the rate is not $< 0.3\\,\\mathrm{mL/kg/h}$.\n    - The UO-based stage is **Stage 2**.\n\n3.  **Overall Staging**:\n    - The overall stage is $\\max(2, 2) = 2$.\n    - The KDIGO stage at $48$ hours is **2**.\n\n**Analysis at $t = 72$ hours**\n\n1.  **Serum Creatinine (SCr) Staging**:\n    - The ratio of current SCr to baseline is $\\frac{SCr_{72}}{SCr_{base}} = \\frac{2.4\\,\\mathrm{mg/dL}}{0.8\\,\\mathrm{mg/dL}} = 3.0$. This meets the Stage $3$ criterion ($\\ge 3.0$ times baseline).\n    - The SCr-based stage is **Stage 3**.\n\n2.  **Urine Output (UO) Staging**:\n    - The average UO rate over the interval $(48, 72]\\,\\mathrm{h}$ (duration $24\\,\\mathrm{h}$) is $\\frac{V_3}{BW \\times \\Delta t} = \\frac{500\\,\\mathrm{mL}}{80\\,\\mathrm{kg} \\times 24\\,\\mathrm{h}} = \\frac{500}{1920}\\,\\mathrm{mL/kg/h} \\approx 0.260\\,\\mathrm{mL/kg/h}$.\n    - This rate is $< 0.3\\,\\mathrm{mL/kg/h}$. Since it persisted for $24\\,\\mathrm{h}$, it meets the Stage $3$ criterion.\n    - The UO-based stage is **Stage 3**.\n\n3.  **Overall Staging**:\n    - The overall stage is $\\max(3, 3) = 3$.\n    - The KDIGO stage at $72$ hours is **3**.\n\n**Justification for Discrepancy**\nAt the $24$-hour time point, a discrepancy exists: the SCr criterion indicates Stage $1$ AKI, while the UO criterion indicates no AKI (Stage $0$). This represents a state of non-oliguric AKI. Serum creatinine accumulation is a lagging indicator of reduced glomerular filtration rate (GFR), while urine output can reflect both GFR and tubular function. In this initial phase, the renal injury was sufficient to impair creatinine clearance (elevating SCr), but not severe enough to reduce urine volume below the oliguric threshold defined by KDIGO. This discordance is common in clinical practice, as the two parameters do not always change in perfect synchrony. By $48$ hours, the progression of the kidney injury leads to concordance between both SCr and UO criteria.",
            "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n1 & 2 & 3\n\\end{pmatrix}\n}\n$$"
        },
        {
            "introduction": "While standardized criteria like KDIGO are essential, it is crucial to recognize their limitations and think critically about the data. This exercise presents a common clinical scenario where serum creatinine rises, meeting the formal definition of AKI, yet does not reflect a true decline in glomerular filtration rate (GFR). Understanding this phenomenon, often called a \"creatinine bump,\" is vital for avoiding misdiagnosis and preventing unnecessary or harmful interventions. ",
            "id": "4316677",
            "problem": "A $58$-year-old man with well-controlled type $2$ diabetes mellitus and a recent baseline serum creatinine of $1.0$ milligrams per deciliter presents for follow-up $3$ days after starting oral trimethoprim-sulfamethoxazole at a dose of $160$/$800$ milligrams twice daily for suspected cellulitis. He is euvolemic on examination, his blood pressure is $124$/$76$ millimeters of mercury, heart rate is $78$ beats per minute, and he reports good oral intake. Over the past $24$ hours, his urine output has averaged $0.8$ milliliters per kilogram per hour. Laboratory data show serum creatinine increased from $1.0$ to $1.4$ milligrams per deciliter within $24$ hours of initiating therapy; blood urea nitrogen remains $16$ milligrams per deciliter. Urinalysis is bland without protein, hematuria, or casts. Serum cystatin C is unchanged at $1.0$ milligrams per liter. The hospital laboratory uses an enzymatic creatinine assay rather than the Jaffe method. At $72$ hours, without any intervention, serum creatinine returns to $1.0$ milligrams per deciliter while the antibiotic is continued. Based on serial measurements, the patient meets the definition of acute kidney injury using the Kidney Disease: Improving Global Outcomes (KDIGO) framework.\n\nWhich option best identifies the most likely mechanism for this transient creatinine rise, and specifies the conditions under which KDIGO staging may overcall injury in such cases, along with an appropriate management approach?\n\nA. Medication-induced inhibition of proximal tubular creatinine secretion producing a benign “creatinine bump”; KDIGO may overcall injury when serum creatinine rises from impaired secretion or assay artifacts despite normal urine output, stable hemodynamics, bland urinalysis, and stable cystatin C; continue therapy and monitor.\n\nB. Prerenal azotemia due to occult volume depletion; KDIGO only overcalls injury when urine output is low, so aggressive intravenous fluids are indicated even with normal examination and stable cystatin C.\n\nC. Early obstructive uropathy from prostatism; KDIGO accurately stages true injury here, and urgent bladder catheterization is required despite normal urine output and a bland urinalysis.\n\nD. Structural ischemic acute tubular necrosis triggered by renin-angiotensin-aldosterone system blockade, necessitating upstaging and discontinuation of the causative drug, since any creatinine rise during treatment reflects nephron damage rather than hemodynamic or secretory effects.",
            "solution": "## Solution Derivation\n\nThe central task is to identify the mechanism of the creatinine rise and the appropriate clinical response, considering the discordance between different markers of renal function.\n\n1.  **Analysis of Renal Function**:\n    *   **Serum Creatinine (SCr) vs. KDIGO**: The patient's SCr increased by $0.4$ mg/dL (from $1.0$ to $1.4$ mg/dL) in $24$ hours. This meets the KDIGO definition for Stage $1$ AKI ($\\ge 0.3$ mg/dL rise in $48$ hours). However, SCr is a surrogate marker for GFR and is influenced by non-GFR determinants, primarily tubular secretion.\n    *   **Trimethoprim's Effect**: Trimethoprim blocks the tubular secretion of creatinine. This reduces creatinine clearance and raises serum levels without affecting the actual GFR. The observed SCr increase of $0.4$ mg/dL is typical for this benign pharmacological effect.\n    *   **Cystatin C**: Serum cystatin C is a more specific marker of GFR as its level is not dependent on tubular secretion. The fact that the patient's cystatin C level remained unchanged ($1.0$ mg/L) is very strong evidence that the GFR did not actually decrease.\n    *   **Urine Output (UOP)**: The patient's UOP of $0.8$ mL/kg/hr is normal (typical normal UOP is $0.5 - 1.0$ mL/kg/hr). This argues against significant hemodynamic compromise (prerenal AKI), structural damage (intrinsic AKI), or obstruction (postrenal AKI).\n    *   **Blood Urea Nitrogen (BUN)**: The BUN is stable at $16$ mg/dL. The BUN/SCr ratio decreased from $16:1$ to $16:1.4$ (approximately $11.4:1$). An elevated BUN/SCr ratio ($>20:1$) would suggest a prerenal state, which is not present here.\n    *   **Urinalysis**: A \"bland\" urinalysis, with no cells, casts, or protein, is inconsistent with intrinsic renal pathologies like acute tubular necrosis (ATN), which would show muddy brown casts, or acute interstitial nephritis (AIN), which would show white blood cells and possibly white blood cell casts.\n\n2.  **Synthesis and Conclusion**: The collection of findings—an isolated rise in SCr that meets formal AKI criteria, in the context of a new medication known to inhibit creatinine secretion, combined with normal urine output, a bland urinalysis, and a stable serum cystatin C—points unequivocally to a benign, pharmacological elevation of creatinine that does not represent true kidney injury. This situation highlights a key limitation of the KDIGO criteria: its high sensitivity can lead to a low specificity, \"overcalling\" AKI in cases of pseudo-AKI where GFR is preserved. The correct management is to recognize this phenomenon and, if the medication is necessary, continue it with monitoring, rather than initiating potentially harmful interventions. The subsequent return of SCr to baseline confirms the transient and non-injurious nature of the event.\n\n## Option-by-Option Analysis\n\n**A. Medication-induced inhibition of proximal tubular creatinine secretion producing a benign “creatinine bump”; KDIGO may overcall injury when serum creatinine rises from impaired secretion or assay artifacts despite normal urine output, stable hemodynamics, bland urinalysis, and stable cystatin C; continue therapy and monitor.**\n*   **Evaluation**: This option correctly identifies the mechanism as inhibition of tubular creatinine secretion by trimethoprim. It correctly identifies the phenomenon as a \"creatinine bump.\" It accurately describes the precise conditions (present in this patient) under which the creatinine-based KDIGO staging can overcall a true injury. Finally, it recommends the correct management approach: continuing the necessary antibiotic therapy with observation. This option aligns perfectly with the derived solution.\n\n**B. Prerenal azotemia due to occult volume depletion; KDIGO only overcalls injury when urine output is low, so aggressive intravenous fluids are indicated even with normal examination and stable cystatin C.**\n*   **Evaluation**: This option is incorrect for several reasons. The patient is euvolemic on exam with good intake. The BUN/SCr ratio is not elevated. The unchanged cystatin C argues against a GFR drop. The statement that \"KDIGO only overcalls injury when urine output is low\" is false; the criteria are disjunctive (creatinine OR urine output), and this case is an example of overcalling based on creatinine despite normal urine output. Recommending aggressive fluids for a euvolemic patient is inappropriate and potentially harmful.\n\n**C. Early obstructive uropathy from prostatism; KDIGO accurately stages true injury here, and urgent bladder catheterization is required despite normal urine output and a bland urinalysis.**\n*   **Evaluation**: This mechanism is inconsistent with the data. Obstructive uropathy sufficient to raise creatinine would typically cause a reduction in urine output, which is not seen here ($0.8$ mL/kg/hr is normal). The subsequent spontaneous resolution of the creatinine elevation while the medication is continued also argues against a fixed obstruction. Urgent catheterization is an unnecessary invasive procedure in this context.\n\n**D. Structural ischemic acute tubular necrosis triggered by renin-angiotensin-aldosterone system blockade, necessitating upstaging and discontinuation of the causative drug, since any creatinine rise during treatment reflects nephron damage rather than hemodynamic or secretory effects.**\n*   **Evaluation**: This option is fundamentally flawed. There is no evidence of structural damage; the bland urinalysis argues against ATN. The patient is not described as being on a RAAS blocker. Most critically, the assertion that \"any creatinine rise during treatment reflects nephron damage\" is a dangerous oversimplification and is factually incorrect. It ignores well-established non-GFR-related causes of creatinine elevation, such as the secretion inhibition central to this case. Discontinuation of a needed antibiotic based on this faulty premise would be a clinical error.",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "After identifying AKI, the next crucial step is determining its underlying cause, most commonly differentiating between prerenal (perfusion-related) and intrinsic (structural) kidney damage. This hands-on problem guides you from the first principles of renal physiology to derive the formula for the fractional excretion of sodium ($\\text{FeNa}$), a powerful diagnostic tool. By calculating and interpreting $\\text{FeNa}$ in a clinical context, you will see how a simple ratio of electrolytes can reveal the functional integrity of the renal tubules. ",
            "id": "4759838",
            "problem": "A hospitalized adult develops acute kidney injury (AKI) after gastrointestinal fluid losses. You are given the following contemporaneous laboratory values, obtained prior to any diuretic administration:\n- Plasma sodium concentration: $142$ mmol/L\n- Urine sodium concentration: $8$ mmol/L\n- Plasma creatinine concentration: $2.1$ mg/dL\n- Urine creatinine concentration: $98$ mg/dL\n\nStarting only from core renal physiology definitions, derive an expression for the fractional excretion of sodium (FeNa) that relates $U_{Na}$, $P_{Na}$, $U_{Cr}$, and $P_{Cr}$, using the following foundational facts:\n- The excreted load of a solute equals its urine concentration multiplied by urine flow rate.\n- The filtered load of a freely filtered solute equals the glomerular filtration rate (GFR) multiplied by its plasma concentration.\n- In steady state and in the absence of significant tubular secretion or reabsorption of creatinine, GFR is approximated by creatinine clearance.\n\nThen, compute FeNa for this patient using your derived expression. Express FeNa as a pure number (dimensionless, no percent sign), and round your answer to three significant figures. Finally, based on established pathophysiologic interpretation, explain how typical FeNa thresholds discriminate prerenal azotemia from intrinsic AKI, and categorize the likely mechanism in this case using those thresholds.",
            "solution": "The problem requires a three-part response: the derivation of an expression for the fractional excretion of sodium (FeNa), the calculation of FeNa for the given patient data, and the pathophysiological interpretation of the result.\n\n**Part 1: Derivation of the FeNa Expression**\n\nThe fractional excretion of sodium, $\\text{FeNa}$, is defined as the fraction of the sodium filtered by the glomeruli that is ultimately excreted in the urine. This can be expressed as the ratio of the rate of sodium excretion to the rate of sodium filtration:\n$$ \\text{FeNa} = \\frac{\\text{Sodium Excreted}}{\\text{Sodium Filtered}} $$\n\nWe will formalize the numerator and denominator using the provided foundational facts.\n\nLet $U_{Na}$ be the urine sodium concentration and $P_{Na}$ be the plasma sodium concentration.\nLet $V$ be the urine flow rate.\n\nAccording to the first principle provided, the excreted load (or rate of excretion) of a solute equals its urine concentration multiplied by the urine flow rate. For sodium, this is:\n$$ \\text{Sodium Excreted} = U_{Na} \\times V $$\n\nAccording to the second principle, the filtered load of a freely filtered solute equals the glomerular filtration rate ($GFR$) multiplied by its plasma concentration. Sodium is freely filtered. Therefore:\n$$ \\text{Sodium Filtered} = P_{Na} \\times GFR $$\n\nSubstituting these expressions back into the definition of $\\text{FeNa}$:\n$$ \\text{FeNa} = \\frac{U_{Na} \\times V}{P_{Na} \\times GFR} $$\n\nThe urine flow rate $V$ and the $GFR$ are not directly provided. However, the third principle states that in a steady state, $GFR$ can be approximated by the clearance of creatinine ($C_{Cr}$), as creatinine is freely filtered and undergoes negligible tubular secretion or reabsorption.\n\nThe clearance of any substance $x$ is defined as the volume of plasma from which the substance is completely removed per unit time. It is calculated as:\n$$ C_x = \\frac{U_x \\times V}{P_x} $$\nwhere $U_x$ is the urine concentration and $P_x$ is the plasma concentration of the substance.\n\nApplying this definition to creatinine, with $U_{Cr}$ as the urine creatinine concentration and $P_{Cr}$ as the plasma creatinine concentration, we get the creatinine clearance:\n$$ C_{Cr} = \\frac{U_{Cr} \\times V}{P_{Cr}} $$\n\nUsing the approximation $GFR \\approx C_{Cr}$, we can write:\n$$ GFR \\approx \\frac{U_{Cr} \\times V}{P_{Cr}} $$\n\nNow, we substitute this expression for $GFR$ into our equation for $\\text{FeNa}$:\n$$ \\text{FeNa} = \\frac{U_{Na} \\times V}{P_{Na} \\times \\left( \\frac{U_{Cr} \\times V}{P_{Cr}} \\right)} $$\n\nThe urine flow rate, $V$, appears in both the numerator and the denominator, so it can be canceled out:\n$$ \\text{FeNa} = \\frac{U_{Na}}{P_{Na} \\times \\left( \\frac{U_{Cr}}{P_{Cr}} \\right)} $$\n\nRearranging this expression gives the final, practical formula for $\\text{FeNa}$:\n$$ \\text{FeNa} = \\frac{U_{Na} \\times P_{Cr}}{P_{Na} \\times U_{Cr}} $$\n\nThis derived expression relates the four provided laboratory values ($U_{Na}$, $P_{Na}$, $U_{Cr}$, and $P_{Cr}$) and allows for the calculation of $\\text{FeNa}$ from a single spot urine sample and a contemporaneous blood sample, without needing a timed urine collection to measure $V$.\n\n**Part 2: Calculation of FeNa**\n\nWe are given the following values:\n- Plasma sodium concentration: $P_{Na} = 142 \\text{ mmol/L}$\n- Urine sodium concentration: $U_{Na} = 8 \\text{ mmol/L}$\n- Plasma creatinine concentration: $P_{Cr} = 2.1 \\text{ mg/dL}$\n- Urine creatinine concentration: $U_{Cr} = 98 \\text{ mg/dL}$\n\nUsing the derived formula:\n$$ \\text{FeNa} = \\frac{U_{Na} \\times P_{Cr}}{P_{Na} \\times U_{Cr}} $$\n\nSubstituting the numerical values:\n$$ \\text{FeNa} = \\frac{(8 \\text{ mmol/L}) \\times (2.1 \\text{ mg/dL})}{(142 \\text{ mmol/L}) \\times (98 \\text{ mg/dL})} $$\n\nThe units (mmol/L and mg/dL) cancel, yielding a dimensionless number as expected for a fraction.\n$$ \\text{FeNa} = \\frac{16.8}{13916} \\approx 0.00120724346... $$\n\nThe problem requires the answer to be rounded to three significant figures. The first three significant digits are $1$, $2$, and $0$. The fourth significant digit is $7$, which is $\\ge 5$, so we round up the third significant digit.\n$$ \\text{FeNa} \\approx 0.00121 $$\n\n**Part 3: Pathophysiologic Interpretation**\n\nThe fractional excretion of sodium is a critical tool for differentiating between the major categories of acute kidney injury (AKI), specifically between prerenal azotemia and intrinsic AKI, particularly acute tubular necrosis (ATN). The interpretation relies on understanding the kidney's physiological response to different insults.\n\nEstablished clinical thresholds for $\\text{FeNa}$ (expressed as a percentage) are:\n- $\\text{FeNa} < 1\\%$ (or as a fraction, $\\text{FeNa} < 0.01$): This is characteristic of **prerenal azotemia**. In prerenal states, such as hypovolemia from gastrointestinal losses, renal perfusion is decreased. The kidneys perceive this as a loss of effective circulating volume and activate compensatory mechanisms, primarily the renin-angiotensin-aldosterone system. Aldosterone acts on the distal tubules and collecting ducts to increase the reabsorption of sodium (and water). The renal tubules are structurally and functionally intact, and their avid reabsorption of sodium leads to a very low concentration of sodium in the urine relative to the amount filtered.\n- $\\text{FeNa} > 2\\%$ (or as a fraction, $\\text{FeNa} > 0.02$): This is characteristic of **intrinsic AKI**, most commonly acute tubular necrosis (ATN). In ATN, the tubular epithelial cells are damaged. This damage impairs their ability to reabsorb solutes, including sodium. Consequently, a larger fraction of the filtered sodium is \"wasted\" into the urine, leading to a high $\\text{FeNa}$.\n\nThe calculated $\\text{FeNa}$ for this patient is $0.00121$.\nTo compare this with the standard thresholds, we can express it as a percentage: $0.00121 \\times 100\\% = 0.121\\%$.\n\nThis value of $0.121\\%$ is significantly less than the $1\\%$ threshold. This very low $\\text{FeNa}$ indicates that the renal tubules are aggressively conserving sodium, a hallmark of an intact tubular system responding to perceived volume depletion. This finding is highly consistent with the clinical history of acute kidney injury developing after gastrointestinal fluid losses.\n\nTherefore, the likely mechanism of AKI in this patient is **prerenal azotemia** secondary to hypovolemia. The kidney itself is not damaged; its function is impaired due to inadequate perfusion. This distinction is crucial as prerenal AKI is often reversible with restoration of fluid volume, whereas intrinsic AKI represents structural damage to the kidney parenchyma. The provided data strongly suggest the former case. It is important to note that these thresholds are most reliable in patients who have not received diuretics, a condition specified in the problem statement.",
            "answer": "$$\\boxed{0.00121}$$"
        }
    ]
}